Disease Markers

Table of Contents: 2012

  • Disease Markers -
  • Special Issue
  • Volume 32
  • - Article ID 234136

BRCA1 and BRCA2 Unclassified Variants and Missense Polymorphisms in Algerian Breast/Ovarian Cancer Families

Farid Cherbal | Nadjet Salhi | ... | Philippe Maillet
  • Disease Markers -
  • Special Issue
  • Volume 33
  • - Article ID 737169

Relation between MicroRNA Expression in Peritoneal Dialysis Effluent and Peritoneal Transport Characteristics

Jin Chen | Philip Kam-Tao | ... | Cheuk-Chun Szeto
  • Disease Markers -
  • Special Issue
  • Volume 32
  • - Article ID 854150

Impact of Renin-Angiotensin-Aldosterone System Gene Polymorphisms on Left Ventricular Dysfunction in Coronary Artery Disease Patients

Avshesh Mishra | Anshika Srivastava | ... | B. Mittal
  • Disease Markers -
  • Special Issue
  • Volume 32
  • - Article ID 737132

Limited Value of KAI1/CD82 Protein Expression as a Prognostic Marker in Human Gastric Cancer

Maximilian Knoener | Till Krech | ... | Matthias Christgen
  • Disease Markers -
  • Special Issue
  • Volume 33
  • - Article ID 741676

Caveolin-1 Expression in Thyroid Neoplasia Spectrum: Comparison of Two Commercial Antibodies

Jelena Janković | Svetlana Paskaš | ... | Svetlana Savin
  • Disease Markers -
  • Special Issue
  • Volume 33
  • - Article ID 673452

Association of the HindIII and S447X Polymorphisms in LPL Gene with Hypertension and Type 2 Diabetes in Mexican Families

Salvador Muñoz-Barrios | Iris Paola Guzmán-Guzmán | ... | Isela Parra-Rojas
  • Disease Markers -
  • Special Issue
  • Volume 32
  • - Article ID 562862

Eicosanoids in Exhaled Breath Condensate and Bronchoalveolar Lavage Fluid of Patients with Primary Lung Cancer

Maciej Ciebiada | Paweł Górski | Adam Antczak
  • Disease Markers -
  • Special Issue
  • Volume 32
  • - Article ID 269279

Abnormal Expression of Matrix Metalloproteinase-9 (MMP9) Correlates with Clinical Course in Chinese Patients with Endometrial Cancer

Fang Yu | Qingping Jiang | ... | Suiqun Guo
  • Disease Markers -
  • Special Issue
  • Volume 33
  • - Article ID 612030

Susceptibility to Toxoplasmic Retinochoroiditis Is Associated with Hla Alleles Reported to Be Implicated with Rapid Progression to Aids

Ana Lúcia G. Demarco | Maria de Lourdes V. Rodrigues | ... | Eduardo A. Donadi
  • Disease Markers -
  • Special Issue
  • Volume 32
  • - Article ID 706745

Plasma Seprase and DPP4 Levels as Markers of Disease and Prognosis in Cancer

Mazyar Javidroozi | Stanley Zucker | Wen-Tien Chen
  • Disease Markers -
  • Special Issue
  • Volume 33
  • - Article ID 324696

Decrease in Antioxidant Status of Plasma and Erythrocytes from Geriatric Population

Manjulata Kumawat | Tarun Kumar Sharma | ... | Satish Kumar Vardey
  • Disease Markers -
  • Special Issue
  • Volume 32
  • - Article ID 757302

Association of the Wild-Type A/A Genotype of MBL2 Codon 54 with Asthma in a North Indian Population

Niti Birbian | Jagtar Singh | ... | Neha Singla
  • Disease Markers -
  • Special Issue
  • Volume 33
  • - Article ID 167143

Oxidized Low-Density Lipoprotein Cholesterol and the Ratio in the Diagnosis and Evaluation of Therapeutic Effect In Patients with Coronary Artery Disease

Huiling Huang | R. Ma | ... | Yugang Dong
  • Disease Markers -
  • Special Issue
  • Volume 33
  • - Article ID 629814

IL-23 Gene Expression in PBMCs of Patients with Coronary Artery Disease

Maryam Khojasteh-Fard | Milad Abolhalaj | ... | Mahsa M. Amoli
  • Disease Markers -
  • Special Issue
  • Volume 32
  • - Article ID 479275

Elevated IL-1α and CXCL10 Serum Levels Occur in Patients with Homozygous Sickle Cell Disease and a History of Acute Splenic Sequestration

Adel Driss | Nana O. Wilson | ... | Jonathan K. Stiles
Disease Markers
 Journal metrics
See full report
Acceptance rate6%
Submission to final decision131 days
Acceptance to publication42 days
CiteScore3.700
Journal Citation Indicator-
Impact Factor-

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.